MMWR Morb Mortal Wkly Rep. 2021 Feb 12;70(6):217-222. doi: 10.15585/mmwr.mm7006e3.
As of February 8, 2021, 59.3 million doses of vaccines to prevent coronavirus disease 2019 (COVID-19) had been distributed in the United States, and 31.6 million persons had received at least 1 dose of the COVID-19 vaccine (1). However, national polls conducted before vaccine distribution began suggested that many persons were hesitant to receive COVID-19 vaccination (2). To examine perceptions toward COVID-19 vaccine and intentions to be vaccinated, in September and December 2020, CDC conducted household panel surveys among a representative sample of U.S. adults. From September to December, vaccination intent (defined as being absolutely certain or very likely to be vaccinated) increased overall (from 39.4% to 49.1%); the largest increase occurred among adults aged ≥65 years. If defined as being absolutely certain, very likely, or somewhat likely to be vaccinated, vaccination intent increased overall from September (61.9%) to December (68.0%). Vaccination nonintent (defined as not intending to receive a COVID-19 vaccination) decreased among all adults (from 38.1% to 32.1%) and among most sociodemographic groups. Younger adults, women, non-Hispanic Black (Black) persons, adults living in nonmetropolitan areas, and adults with lower educational attainment, with lower income, and without health insurance were most likely to report lack of intent to receive COVID-19 vaccine. Intent to receive COVID-19 vaccine increased among adults aged ≥65 years by 17.1 percentage points (from 49.1% to 66.2%), among essential workers by 8.8 points (from 37.1% to 45.9%), and among adults aged 18-64 years with underlying medical conditions by 5.3 points (from 36.5% to 41.8%). Although confidence in COVID-19 vaccines increased during September-December 2020 in the United States, additional efforts to tailor messages and implement strategies to further increase the public's confidence, overall and within specific subpopulations, are needed. Ensuring high and equitable vaccination coverage across all populations is important to prevent the spread of COVID-19 and mitigate the impact of the pandemic.
截至 2021 年 2 月 8 日,美国已分发了 5930 万剂预防 2019 年冠状病毒病(COVID-19)的疫苗,有 3160 万人至少接种了 1 剂 COVID-19 疫苗(1)。然而,疫苗分发前进行的全国民意调查显示,许多人对接种 COVID-19 犹豫不决(2)。为了了解公众对 COVID-19 疫苗的看法和接种意愿,疾病预防控制中心于 2020 年 9 月和 12 月在美国成年人中进行了代表性的家庭小组调查。从 9 月到 12 月,接种意愿(定义为绝对肯定或非常可能接种疫苗)总体上有所增加(从 39.4%增加到 49.1%);增幅最大的是 65 岁及以上的成年人。如果将绝对肯定、非常可能或有些可能接种疫苗定义为接种意愿,那么从 9 月(61.9%)到 12 月(68.0%),接种意愿总体上有所增加。所有成年人(从 38.1%降至 32.1%)和大多数社会人口统计学群体的非接种意愿(即不打算接种 COVID-19 疫苗)均有所下降。较年轻的成年人、女性、非西班牙裔黑人(黑人)、居住在非大都市地区的成年人以及教育程度较低、收入较低和没有医疗保险的成年人最不可能报告没有接种 COVID-19 疫苗的意愿。65 岁及以上成年人的接种意愿增加了 17.1 个百分点(从 49.1%增加到 66.2%),基本工人增加了 8.8 个百分点(从 37.1%增加到 45.9%),18-64 岁有基础疾病的成年人增加了 5.3 个百分点(从 36.5%增加到 41.8%)。尽管 2020 年 9 月至 12 月期间,美国公众对 COVID-19 疫苗的信心有所增强,但仍需进一步努力,调整信息,实施战略,以进一步增强公众的信心,无论在总体上还是在特定人群中。确保所有人群的高接种率和公平接种率对于防止 COVID-19 的传播和减轻大流行的影响非常重要。